103 related articles for article (PubMed ID: 25117853)
1. Population dose-response analysis of daily seizure count following vigabatrin therapy in adult and pediatric patients with refractory complex partial seizures.
Nielsen JC; Hutmacher MM; Wesche DL; Tolbert D; Patel M; Kowalski KG
J Clin Pharmacol; 2015 Jan; 55(1):81-92. PubMed ID: 25117853
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin pediatric dosing information for refractory complex partial seizures: results from a population dose-response analysis.
Nielsen JC; Tolbert D; Patel M; Kowalski KG; Wesche DL
Epilepsia; 2014 Dec; 55(12):e134-8. PubMed ID: 25311090
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
Bruni J; Guberman A; Vachon L; Desforges C
Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
[TBL] [Abstract][Full Text] [Related]
4. Dose-response study of vigabatrin in children with refractory epilepsy.
Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics analysis of vigabatrin in adults and children with epilepsy and children with infantile spasms.
Nielsen JC; Kowalski KG; Karim A; Patel M; Wesche DL; Tolbert D
Clin Pharmacokinet; 2014 Nov; 53(11):1019-31. PubMed ID: 25172554
[TBL] [Abstract][Full Text] [Related]
6. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.
Miller R; Frame B; Corrigan B; Burger P; Bockbrader H; Garofalo E; Lalonde R
Clin Pharmacol Ther; 2003 Jun; 73(6):491-505. PubMed ID: 12811359
[TBL] [Abstract][Full Text] [Related]
7. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
Arteaga R; Herranz JL; Valdizán EM; Armijo JA
Epilepsia; 1992; 33(5):923-31. PubMed ID: 1396437
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of the effectiveness and safety of vigabatrin].
Jedrzejczak J; Owczarek K
Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin: a novel therapy for seizure disorders.
Gidal BE; Privitera MD; Sheth RD; Gilman JT
Ann Pharmacother; 1999 Dec; 33(12):1277-86. PubMed ID: 10630829
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin therapy for refractory complex partial seizures: review of major European trials.
Ben-Menachem E; Sander JW
Acta Neurol Scand Suppl; 2011; (192):16-28. PubMed ID: 22061177
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
[TBL] [Abstract][Full Text] [Related]
13. Modeling longitudinal daily seizure frequency data from pregabalin add-on treatment.
Ahn JE; Plan EL; Karlsson MO; Miller R
J Clin Pharmacol; 2012 Jun; 52(6):880-92. PubMed ID: 21646441
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of vigabatrin dose for the treatment of refractory focal seizures in children using adult and pediatric data.
Rodrigues C; Chiron C; Ounissi M; Dulac O; Gaillard S; Nabbout R; Jullien V
Epilepsy Res; 2019 Feb; 150():38-45. PubMed ID: 30639958
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin in pediatric patients with refractory epilepsy.
Turanli G; Celebi A; Yalnizoğlu D; Topçu M; Topaloğlu H; Banu A; Aysun S
Turk J Pediatr; 2006; 48(1):25-30. PubMed ID: 16562782
[TBL] [Abstract][Full Text] [Related]
16. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
Gidal BE; Ferry J; Majid O; Hussein Z
Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin in pediatric epilepsy--an open study.
Uldall P; Alving J; Gram L; Beck S
J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
[TBL] [Abstract][Full Text] [Related]
18. Vigabatrin.
Connelly JF
Ann Pharmacother; 1993 Feb; 27(2):197-204. PubMed ID: 8439699
[TBL] [Abstract][Full Text] [Related]
19. Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures.
Schoemaker R; Wade JR; Stockis A
J Clin Pharmacol; 2016 Dec; 56(12):1591-1602. PubMed ID: 27146213
[TBL] [Abstract][Full Text] [Related]
20. Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.
Faught E
Acta Neurol Scand Suppl; 2011; (192):29-35. PubMed ID: 22061178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
